Connective Tissue Disease-Associated Pulmonary Arterial Hypertension

被引:14
|
作者
Sung, Yon K. [1 ]
Chung, Lorinda [2 ,3 ]
机构
[1] Stanford Univ, Sch Med, Div Pulm & Crit Care Med, Vera Moulton Wall Ctr Pulm Vasc Dis, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA
[3] VA Palo Alto Hlth Care Syst, Div Rheumatol, Palo Alto, CA 94304 USA
关键词
Pulmonary hypertension; Pulmonary arterial hypertension; Connective tissue disease; Systemic sclerosis; Systemic lupus erythematosus; Mixed connective tissue disease; ANTIENDOTHELIAL CELL ANTIBODIES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; IMMUNOSUPPRESSIVE THERAPY; CLINICAL CHARACTERISTICS; RISK-FACTORS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; ENDOTHELIAL INJURY; SCLEROSIS; PREVALENCE;
D O I
10.1016/j.rdc.2015.01.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pulmonary arterial hypertension (PAH) is characterized by vascular remodeling of pulmonary arterioles that leads to increased pulmonary vascular resistance, right heart failure, and death. It is associated with connective tissue diseases, including systemic sclerosis, systemic lupus erythematosus, and mixed connective tissue disease. PAH is characterized by dyspnea on exertion and fatigue. Syncopal events suggest severe disease. Patients may present with signs of right heart failure. One- and 3-year survival rates are approximately 81% and 52%, respectively. Given the high prevalence and mortality, algorithms for screening are currently under investigation and will hopefully lead to earlier diagnosis and improved survival.
引用
收藏
页码:295 / +
页数:20
相关论文
共 50 条
  • [1] Connective tissue disease-associated pulmonary arterial hypertension in Chinese patients
    Hao, Yan-Jie
    Jiang, Xin
    Zhou, Wei
    Wang, Yong
    Gao, Lan
    Wang, Yu
    Li, Guang-Tao
    Hong, Tao
    Huo, Yong
    Jing, Zhi-Cheng
    Zhang, Zhuo-Li
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 963 - 972
  • [2] Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension
    Kularatne, Mithum
    Boucly, Athenais
    Savale, Laurent
    Solinas, Sabina
    Cheron, Celine
    Roche, Anne
    Jevnikar, Mitja
    Jais, Xavier
    Montani, David
    Humbert, Marc
    Sitbon, Olivier
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2101 - 2115
  • [3] Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension
    Gaine, Sean
    Chin, Kelly
    Coghlan, Gerry
    Channick, Richard
    Di Scala, Lilla
    Galie, Nazzareno
    Ghofrani, Hossein-Ardeschir
    Lang, Irene M.
    McLaughlin, Vallerie
    Preiss, Ralph
    Rubin, Lewis J.
    Simonneau, Gerald
    Sitbon, Olivier
    Tapson, Victor F.
    Hoeper, Marius M.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
  • [4] Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
    Moccaldi, Beatrice
    De Michieli, Laura
    Binda, Marco
    Famoso, Giulia
    Depascale, Roberto
    Perazzolo Marra, Martina
    Doria, Andrea
    Zanatta, Elisabetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [5] Connective tissue disease-associated pulmonary arterial hypertension: "Beijing style"
    Chung, Lorinda
    Kawut, Steven M.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (04) : 839 - 841
  • [6] Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
    Rhee, Rennie L.
    Gabler, Nicole B.
    Praestgaard, Amy
    Merkel, Peter A.
    Kawut, Steven M.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (09) : 2457 - 2465
  • [7] Adverse Events In Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Compared To Idiopathic Pulmonary Arterial Hypertension
    Rhee, Rennie L.
    Gabler, Nicole B.
    Praestgaard, Amy
    Merkel, Peter A.
    Kawut, Steven M.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S773 - S773
  • [8] Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
    Khanna, Dinesh
    Gladue, Heather
    Channick, Richard
    Chung, Lorinda
    Distler, Oliver
    Furst, Daniel E.
    Hachulla, Eric
    Humbert, Marc
    Langleben, David
    Mathai, Stephen C.
    Saggar, Rajeev
    Visovatti, Scott
    Altorok, Nezam
    Townsend, Whitney
    FitzGerald, John
    McLaughlin, Vallerie V.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3194 - 3201
  • [9] Connective Tissue Disease-associated Pulmonary Arterial Hypertension in the Modern Treatment Era
    Condliffe, Robin
    Kiely, David G.
    Peacock, Andrew J.
    Corris, Paul A.
    Gibbs, J. Simon R.
    Vrapi, Florenc
    Das, Clare
    Elliot, Charlie A.
    Johnson, Martin
    DeSoyza, Julia
    Torpy, Chantal
    Goldsmith, Kim
    Hodgkins, Denise
    Hughes, Rodney J.
    Pepke-Zaba, Joanna
    Coghlan, J. Gerry
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179 (02) : 151 - 157
  • [10] EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY FOR CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
    Kishikawa, R.
    Hatano, M.
    Ishii, S.
    Shimbo, M.
    Saito, A.
    Minatsuki, S.
    Iwasaki, Y.
    Fujio, K.
    Komuro, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1168 - 1169